BIOMED-LUBLIN Wytw?rnia Surowic i Szczepionek S.A. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was PLN 6.55 million compared to PLN 8.33 million a year ago. Net loss was PLN 0.577 million compared to net income of PLN 0.094 million a year ago. Basic loss per share from continuing operations was PLN 0.01. Diluted loss per share from continuing operations was PLN 0.01. For the nine months, revenue was PLN 26.56 million compared to PLN 28.03 million a year ago. Net income was PLN 1.19 million compared to PLN 0.813 million a year ago. Basic earnings per share from continuing operations was PLN 0.02 compared to PLN 0.01 a year ago. Diluted earnings per share from continuing operations was PLN 0.02 compared to PLN 0.01 a year ago.